HLB Co., Ltd.
028300
Clasificación en acciones
#4138
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Precio por acción
$29.28
Capitalización bursátil
$3.89B
Cambio (1 día)
-1.40%
Cambio (1 año)
-8.45%
País
KR
Comercio HLB Co., Ltd. (028300)
Categoría
Healthcare
Ratio P/B de HLB Co., Ltd. (028300)
Ratio P/B al October 2026 TTM: 15.65
Según los informes financieros más recientes y el precio de las acciones de HLB Co., Ltd., el ratio P/B actual (TTM) es 15.65. Al final de 2023, el ratio P/B era 12.31.
Historial del ratio P/B de HLB Co., Ltd. desde 2012 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 15.65 | -5.53% |
| 2024 | 16.57 | 34.60% |
| 2023 | 12.31 | 162.53% |
| 2022 | 4.69 | -46.47% |
| 2021 | 8.76 | -19.54% |
| 2020 | 10.89 | -58.32% |
| 2019 | 26.12 | 50.87% |
| 2018 | 17.32 | -17.44% |
| 2017 | 20.97 | 262.79% |
| 2016 | 5.78 | -35.05% |
| 2015 | 8.90 | 6.84% |
| 2014 | 8.33 | 133.99% |
| 2013 | 3.56 | 31.96% |
| 2012 | 2.70 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.251 | -60.07% |
US
|
|
| 13.2547 | -15.33% |
US
|
|
| 4.208 | -73.12% |
AU
|
|
| 6.1824 | -60.51% |
NL
|
|
| - | - |
CH
|
